Related Experiment Video

Updated: Mar 14, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

41.8K

Tests for hepatitis C to improve blood safety

    Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
    |September 24, 2016
    PubMed

    Insights

    All blood donations will be screened for hepatitis C starting September 1st. This initiative uses newly developed, advanced testing methods to enhance blood safety for recipients.

    Area of Science:

    • Public Health
    • Infectious Disease Control
    • Virology

    Background:

    • Hepatitis C is a significant public health concern.
    • Blood transfusion safety is paramount for preventing disease transmission.

    Purpose of the Study:

    • To announce and explain the implementation of new hepatitis C testing for all blood donations.
    • To inform stakeholders about enhanced blood safety measures.

    Main Methods:

    • Introduction of recently developed diagnostic tests for hepatitis C virus (HCV).
    • Mandatory screening of all donated blood units.

    Main Results:

    • Improved detection capabilities for hepatitis C in the blood supply.
    • Enhanced safety of blood transfusions for recipients.

    Conclusions:

    • The new testing protocol represents a significant advancement in blood safety.
    • This policy change aims to further reduce the risk of transfusion-transmitted hepatitis C.

    More Related Videos

    A Protocol for Analyzing Hepatitis C Virus Replication13:04

    A Protocol for Analyzing Hepatitis C Virus Replication

    Published on: June 26, 2014

    24.8K
    "Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

    "Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

    Published on: February 19, 2019

    12.3K

    Related Concept Videos

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
    248
    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
    310